Home > Share Market > Stocks > Glenmark Pharmaceuticals Ltd > Financial Statements > GLENMARK Cash Flow

Glenmark Pharmaceuticals Ltd Financial Statements

Glenmark Pharmaceuticals Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 1,338 1,063 1,119 1,572
Depreciation (444) (417) (302) (264)
Tax paid (412) (320) (315) (383)
Working capital 1,587 851 1,419 953
Other operating items -- -- -- --
Operating cashflow 2,069 1,177 1,920 1,879
Capital expenditure 5,381 4,436 1,872 469
Free cash flow 7,450 5,614 3,793 2,348
Equity raised 8,803 8,224 6,145 7,013
Investments 24.60 24.60 (2.50) (1.50)
Debt financing/disposal 7,452 7,429 8,366 8,681
Dividends paid -- -- 56.40 56.40
Other items -- -- -- --
Net in cash 23,730 21,291 18,358 18,097

Invest in at ZERO Delivery Brokerage. Join 22 Lac+ Happy Clients